Company intelligence / Profile preview

Microbial Machines

Andover, Massachusetts, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Microbial Machines is an early-stage biotechnology company developing synthetically engineered probiotic bacteria designed to image, diagnose, and treat diseases within the gastrointestinal tract. The company’s approach leverages synthetic biology to create living medicines that can specifically detect disease states and deliver therapeutic payloads. No clinical results have been published as of May 2025; the company appears to be in preclinical development.[1][3][5]

Therapeutic areas: Gastroenterology
Modalities: Engineered probiotic bacteriaSynthetic biology-based therapeutics and diagnostics[1][3][5][6]
Industry: Biotech

Beyond the preview

Go deeper on Microbial Machines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial Machines.

Explore the full profile